Research Article

A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer

Figure 4

In-depth screening for hub DEGs in CC. (a) mRNA expression levels of candidate hub DEGs evaluated using the Oncomine microarray database. (b) Kaplan-Meier survival analysis and the log-rank test. The mRNA levels of CXCL1 (), CXCL8 (), DSG2 (), MMP1 (), SPP1 (), MCM2 (), HELLS (), and VCAM1 () were significantly associated with OS among CC patients. CC: cervical cancer; DEG: differentially expressed gene; OS: overall survival.
(a)
(b)